Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression

10 Jul 2014

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Breast Cancer Therapies
Share to Breast Cancer Treatment Studies
Share to HER2/EGFR in Cancer Research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 25012601
DOI: 10.1007/s00404-014-3331-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expressionPMID 25012601Read ↗

Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast CancerSemantic proximity Read ↗

Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of researchSemantic proximity Read ↗

Triple-negative breast cancer and the need for new therapeutic targets.Semantic proximity Read ↗

Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.Semantic proximity Read ↗

Clinical implications of molecular heterogeneity in triple negative breast cancer.Semantic proximity Read ↗

Triple-negative breast cancer.Semantic proximity Read ↗

Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer.Semantic proximity Read ↗

Triple-negative breast cancer.Semantic proximity Read ↗

Identification of CCNB2 expression in triple-negative breast cancer based on bioinformatics resultsSemantic proximity Read ↗

Molecular characteristics and prognosis of triple negative breast cancer stratified by HER2 status.Semantic proximity Read ↗

Genetic Markers in Triple-Negative Breast Cancer.Semantic proximity Read ↗

Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.